Pharmaceuticals
NIH to test Pfizer’s Paxlovid, other treatments as potential long Covid therapies
Paxlovid, Pfizer’s anti-viral medication to treat the coronavirus disease (COVID-19), is displayed in this picture illustration taken October 7, 2022. Wolfgang Rattay | Reuters The National Institutes of Health said Monday it launched mid-stage clinical trials to test at least four treatments, including Pfizer‘s antiviral Covid-19 pill Paxlovid, as potential therapies for long Covid. There […]
Read More
New Covid vaccines are coming to the U.S. this fall, but uptake may be low — Here’s why
A pharmacist delivers a COVID-19 booster dose at a Chicago CVS store. Antonio Perez | Tribune News Service | Getty Images A new round of Covid vaccines is coming to the U.S. this fall — but many Americans may not roll up their sleeves and take one. That’s largely because pandemic fatigue, the belief that […]
Read More
Johnson & Johnson effort to resolve talc cancer lawsuits in bankruptcy fails a second time
In this photo illustration, a container of Johnson and Johnson baby powder is displayed on April 05, 2023 in San Anselmo, California. Justin Sullivan | Getty Images A federal bankruptcy judge on Friday rejected Johnson & Johnson‘s second attempt to resolve tens of thousands of lawsuits alleging the company’s talc baby powder and other talc-based […]
Read More
AstraZeneca CFO denies geopolitics impacts the company’s China organization after spinoff rumors
AstraZeneca’s main financial officer on Friday stated that geopolitical tensions are not impacting the firm’s China functions, adhering to a report that the pharma large is contemplating spinning off its small business in the state. “We are in an marketplace that is developing lifestyle-conserving medications, that is helping China and really citizens all throughout the […]
Read More
Eli Lilly says obesity drug helped boost weight loss to 26%, highest seen in late-stage trials
The Eli Lilly logo is shown on one of the company’s offices in San Diego, California, September 17, 2020. Mike Blake | Reuters An Eli Lilly experimental drug helped patients lose about 26% of their weight on average following extended use or intensive lifestyle changes, according to results from two studies released Thursday. It’s the […]
Read More
UK investigates weight loss, diabetes drugs like Wegovy and Ozempic for suicide risks
Packages of the weight-loss drug Wegovy from the pharmaceutical company Novo Nordisk lie on the sales counter in a Danish pharmacy. Stefan Trumpf | Picture Alliance | Getty Images U.K. health authorities on Wednesday said they are reviewing obesity and diabetes drugs like Novo Nordisk‘s Wegovy and Ozempic after some patients who took the treatments […]
Read More
GSK chief says RSV vaccine will start off slower than shingles shot – but will drive future sales
Budrul Chukrut | Lightrocket | Getty Images GlaxoSmithKline CEO Emma Walmsley on Wednesday said she expects uptake for the company’s new RSV vaccine to start off slower than it did for its blockbuster shingles shot. But she is confident that the new vaccine will drive future sales. “I think the uptake on this we need […]
Read More
Weight loss drug Wegovy is from Europe — but users in the region face a long and costly wait
Packages of the weight-loss drug Wegovy from the pharmaceutical company Novo Nordisk lie on the sales counter in a Danish pharmacy. Stefan Trumpf | Picture Alliance | Getty Images Danish pharmaceutical giant Novo Nordisk is set to launch its hugely popular Wegovy obesity drug in Germany this month, but it could be some time before […]
Read More
Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch
A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen on Tuesday said it expects to cut approximately 1,000 jobs, or about 11% of its workforce, to save costs as the biotech company prepares to launch its newly approved Alzheimer’s drug Leqembi. It’s the latest round of layoffs after Biogen slashed nearly 900 jobs […]
Read More
Johnson & Johnson to reduce its Kenvue stake by at least 80% through exchange offer
Kenvue, a unit of Johnson & Johnson’s consumer health business. CFOTO | Future Publishing | Getty Images Johnson & Johnson on Monday said it plans to reduce by at least 80% its stake in Kenvue, the consumer health business it spun out as an independent company earlier this year, via a stock exchange offer. J&J […]
Read More